IPP Bureau
USFDA conducts PAI and GMP inspection of Piramal Pharma's Sellersville facility
By IPP Bureau - January 16, 2023
The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations
Global Hospital's hand transplant recipients to participate in Tata Mumbai Marathon 2023
By IPP Bureau - January 16, 2023
Monika and Prathmesh’s determination to participate in the Dream Run to increase awareness serves as a testament to life changing effects of organ transplants and importance of organ donation
Zydus receives tentative approval from USFDA for Levomilnacipran Extended-Release Capsules
By IPP Bureau - January 16, 2023
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India
Granules India’s Gagillapur facility completes USFDA inspection
By IPP Bureau - January 16, 2023
The company will respond to these observations within the stipulated time period.
Bhupender Yadav lays foundation stone of 100 bedded ESIC Hospital at Agartala
By IPP Bureau - January 16, 2023
The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services
TSCS organizes training program for prevention and eradication of thalassemia & sickle cell
By IPP Bureau - January 16, 2023
A First of its Kind Initiative in Mahbubnagar District for Medical Officers, ANM, Anganwadi workers for prevention of Thalassemia and Sickle Cell anemia as part of Antenatal screening of pregnant women project
China, South Korea, and India driving innovation in medical robotics in APAC, says GlobalData
By IPP Bureau - January 16, 2023
APAC to see a reduction in imported surgical robotics
Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer
By IPP Bureau - January 14, 2023
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
India believes in value based health care...: Dr. Mandaviya
By IPP Bureau - January 14, 2023
Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world
Global (68M) cardiomyopathies market set to reach $9.63 bn by 2031: GlobalData
By IPP Bureau - January 14, 2023
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
Quantumzyme and BEC Chemicals to collaborate for green chemistry development
By IPP Bureau - January 14, 2023
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
135 crore footfalls registered at AB-HWCs
By IPP Bureau - January 13, 2023
Exceeding the target of 1.50 lakh Ayushman Bharat - Health & Wellness Centres (AB-HWC) by 31 December, 2022, more than 1.54 lakh Sub Health Centres and Primary Health Centres have been transformed as AB-HWCs
Govt. planning 10,000 Jan Aushadhi Kendras by March 2024
By IPP Bureau - January 13, 2023
The implementing agency of PMBJP has invited online applications for opening of new Jan Aushadhi Kendras in 651 districts of different States/UTs
Dozee partners British International Investment to transform public healthcare in India
By IPP Bureau - January 13, 2023
The goal of Dozee’s partnership with BII is to improve access to healthcare across India and alleviate the workload of healthcare workers, reduce nurse burnout and fatigue in hospital wards